Protease secretions by the invading blastocyst induce calcium oscillations in endometrial epithelial cells via the protease-activated receptor 2.
Calcium microfluorimetry
Early embryo implantation
Embryo-uterine crosstalk
Endometrium
Protease-activated receptor 2
Serin protease
Trypsin
Journal
Reproductive biology and endocrinology : RB&E
ISSN: 1477-7827
Titre abrégé: Reprod Biol Endocrinol
Pays: England
ID NLM: 101153627
Informations de publication
Date de publication:
15 Apr 2023
15 Apr 2023
Historique:
received:
02
01
2023
accepted:
23
03
2023
medline:
18
4
2023
entrez:
14
4
2023
pubmed:
15
4
2023
Statut:
epublish
Résumé
Early embryo implantation is a complex phenomenon characterized by the presence of an implantation-competent blastocyst and a receptive endometrium. Embryo development and endometrial receptivity must be synchronized and an adequate two-way dialogue between them is necessary for maternal recognition and implantation. Proteases have been described as blastocyst-secreted proteins involved in the hatching process and early implantation events. These enzymes stimulate intracellular calcium signaling pathways in endometrial epithelial cells (EEC). However, the exact molecular players underlying protease-induced calcium signaling, the subsequent downstream signaling pathways and the biological impact of its activation remain elusive. To identify gene expression of the receptors and ion channels of interest in human and mouse endometrial epithelial cells, RNA sequencing, RT-qPCR and in situ hybridization experiments were conducted. Calcium microfluorimetric experiments were performed to study their functional expression. We showed that trypsin evoked intracellular calcium oscillations in EEC of mouse and human, and identified the protease-activated receptor 2 (PAR2) as the molecular entity initiating protease-induced calcium responses in EEC. In addition, this study unraveled the molecular players involved in the downstream signaling of PAR2 by showing that depletion and re-filling of intracellular calcium stores occurs via PLC, IP These findings provide new insights into the blastocyst-derived protease signaling and allocate a key role for PAR2 as maternal sensor for signals released by the developing blastocyst.
Sections du résumé
BACKGROUND
BACKGROUND
Early embryo implantation is a complex phenomenon characterized by the presence of an implantation-competent blastocyst and a receptive endometrium. Embryo development and endometrial receptivity must be synchronized and an adequate two-way dialogue between them is necessary for maternal recognition and implantation. Proteases have been described as blastocyst-secreted proteins involved in the hatching process and early implantation events. These enzymes stimulate intracellular calcium signaling pathways in endometrial epithelial cells (EEC). However, the exact molecular players underlying protease-induced calcium signaling, the subsequent downstream signaling pathways and the biological impact of its activation remain elusive.
METHODS
METHODS
To identify gene expression of the receptors and ion channels of interest in human and mouse endometrial epithelial cells, RNA sequencing, RT-qPCR and in situ hybridization experiments were conducted. Calcium microfluorimetric experiments were performed to study their functional expression.
RESULTS
RESULTS
We showed that trypsin evoked intracellular calcium oscillations in EEC of mouse and human, and identified the protease-activated receptor 2 (PAR2) as the molecular entity initiating protease-induced calcium responses in EEC. In addition, this study unraveled the molecular players involved in the downstream signaling of PAR2 by showing that depletion and re-filling of intracellular calcium stores occurs via PLC, IP
CONCLUSIONS
CONCLUSIONS
These findings provide new insights into the blastocyst-derived protease signaling and allocate a key role for PAR2 as maternal sensor for signals released by the developing blastocyst.
Identifiants
pubmed: 37060079
doi: 10.1186/s12958-023-01085-7
pii: 10.1186/s12958-023-01085-7
pmc: PMC10105462
doi:
Substances chimiques
Receptor, PAR-2
0
Peptide Hydrolases
EC 3.4.-
Calcium
SY7Q814VUP
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
37Subventions
Organisme : Research Council of the KU Leuven
ID : C14/18/106
Organisme : Research Council of the KU Leuven
ID : C14/18/106
Organisme : Research Council of the KU Leuven
ID : C14/18/106
Organisme : Research Council of the KU Leuven
ID : C14/18/106
Organisme : Fonds Wetenschappelijk Onderzoek
ID : G.0D1417N, G.084515N, G.0A6719N, 12R4622N, 12U7918N
Organisme : Fonds Wetenschappelijk Onderzoek
ID : G.0D1417N, G.084515N, G.0A6719N, 12R4622N, 12U7918N
Organisme : Fonds Wetenschappelijk Onderzoek
ID : G.0D1417N, G.084515N, G.0A6719N, 12R4622N, 12U7918N
Organisme : Fonds Wetenschappelijk Onderzoek
ID : G.0D1417N, G.084515N, G.0A6719N, 12R4622N, 12U7918N
Organisme : Fonds Wetenschappelijk Onderzoek
ID : G.0D1417N, G.084515N, G.0A6719N, 12R4622N, 12U7918N
Informations de copyright
© 2023. The Author(s).
Références
Biol Reprod. 2012 May 10;86(5):146, 1-9
pubmed: 22238285
ACS Omega. 2022 May 12;7(20):16939-16951
pubmed: 35647460
Front Endocrinol (Lausanne). 2014 May 13;5:67
pubmed: 24860547
Semin Reprod Med. 2007 Nov;25(6):445-53
pubmed: 17960529
J Pharmacol Exp Ther. 2018 Feb;364(2):246-257
pubmed: 29263243
Sci Rep. 2019 Feb 11;9(1):1779
pubmed: 30741991
J Pharmacol Exp Ther. 1999 Feb;288(2):671-8
pubmed: 9918574
Nat Genet. 2021 Dec;53(12):1698-1711
pubmed: 34857954
Sci Rep. 2014 Feb 06;4:3894
pubmed: 24503642
Rev Endocr Metab Disord. 2002 May;3(2):133-43
pubmed: 12007290
Pharmacol Ther. 2011 Jun;130(3):248-82
pubmed: 21277892
J Pharmacol Exp Ther. 2004 Jun;309(3):1124-31
pubmed: 14976230
Int J Mol Sci. 2019 Dec 18;21(1):
pubmed: 31861484
Dev Cell. 2010 Jan 19;18(1):25-38
pubmed: 20152175
Development. 2017 May 15;144(10):1775-1786
pubmed: 28442471
Biochim Biophys Acta. 2012 Dec;1822(12):1931-42
pubmed: 22634130
Nat Cell Biol. 2017 May;19(5):568-577
pubmed: 28394884
J Biol Chem. 1985 Mar 25;260(6):3440-50
pubmed: 3838314
Nature. 2022 Jan;601(7894):600-605
pubmed: 34856602
Toxicol Pathol. 2015 Aug;43(6):776-93
pubmed: 25739587
Am J Physiol Cell Physiol. 2019 May 1;316(5):C741-C752
pubmed: 30811222
Hum Reprod Update. 2002 Jul-Aug;8(4):333-43
pubmed: 12206468
BMC Bioinformatics. 2011 Aug 04;12:323
pubmed: 21816040
Front Cell Dev Biol. 2021 Aug 09;9:709902
pubmed: 34434932
Nat Med. 2020 Oct;26(10):1644-1653
pubmed: 32929266
Blood Adv. 2020 Nov 24;4(22):5810-5824
pubmed: 33232477
Cell Mol Life Sci. 2007 Aug;64(16):2153-69
pubmed: 17514358
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Cell. 2018 May 17;173(5):1307
pubmed: 29775597
Biol Reprod. 2014 Oct;91(4):98
pubmed: 25187529
Nat Med. 2012 Jul;18(7):1112-7
pubmed: 22729284
PLoS One. 2013;8(2):e56757
pubmed: 23451081
J Vis Exp. 2017 Mar 2;(121):
pubmed: 28287563
J Exp Zool. 1990 Apr;254(1):83-7
pubmed: 2189940
J Physiol. 1993 Sep;469:245-73
pubmed: 8271200
Med Res Rev. 2020 Mar;40(2):683-708
pubmed: 31495942